Faron to Present at H.C. Wainwright Conference
Faron Pharmaceuticals Ltd (“Faron” or the “Company”)Faron Pharmaceuticals to Present at the Virtual H.C. Wainwright 22[nd] Annual Global Investment Conference TURKU – FINLAND, September 9, 2020 – Faron Pharmaceuticals Ltd (“Faron”) (LON: FARN), the clinical stage biopharmaceutical company, today announced that Dr. Markku Jalkanen, Chief Executive Officer of Faron Pharmaceuticals, will present at the virtual H.C. Wainwright 22[nd] Annual Global Investment Conference on Wednesday, September 16, 2020 at 11:00 a.m. ET. To access a live webcast and subsequent archived recording of the